Oral human papillomavirus (HPV) prevalence in youth and cervical HPV prevalence in women attending a youth clinic in Sweden, a follow up-study 2013-2014 after gradual introduction of public HPV vaccination

被引:28
|
作者
Grun, Nathalie [1 ]
Ahrlund-Richter, Andreas [1 ]
Franzen, Joar [1 ]
Mirzaie, Leila [1 ]
Marions, Lena [2 ]
Ramqvist, Torbjorn [1 ]
Dalianis, Tina [1 ]
机构
[1] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden
基金
瑞典研究理事会;
关键词
HPV; oral HPV infection; cervical HPV infection; HPV in youth; HPV vaccination; HIGH-SCHOOL-STUDENTS; RISK-FACTORS; INFECTION; HEALTH;
D O I
10.3109/00365548.2014.964764
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
During 2009-2011, we reported that the oral and cervical prevalence of human papillomavirus (HPV) was high by international standards at 9.3% and 74%, respectively, in youth aged 15-23 years attending a youth clinic in Stockholm. After gradual introduction of public HPV vaccination during 2007-2012, between 2013 and 2014, when 73% of the women were HPV-vaccinated, but not necessarily before their sexual debut, oral HPV prevalence had dropped to 1.4% as compared with 9.3% in 2009-2011 (p < .00001). Cervical HPV prevalence was high and common cervical high-risk types were HPV51, 56, 59, 73, 16, 39, 52, and 53. However, it was shown that HPV16, 31, and 70 were significantly less common among HPV-vaccinated women than among those who had not received the vaccine.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 11 条
  • [1] Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine
    Ahrlund-Richter, Andreas
    Cheng, Liqin
    Hu, Yue O. O.
    Svensson, Mikaela
    Pennhag, Alexandra A. L.
    Ursu, Ramona G.
    Haeggblom, Linnea
    Grun, Nathalie
    Ramqvist, Torbjorn
    Engstrand, Lars
    Dalianis, Tina
    Du, Juan
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2019, 9
  • [2] Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection
    Meyer, Moritz F.
    Huebbers, Christian U.
    Siefer, Oliver G.
    Vent, Julia
    Engbert, Iris
    Eslick, Guy D.
    Valter, Markus
    Klussmann, Jens Peter
    Preuss, Simon F.
    ORAL ONCOLOGY, 2014, 50 (01) : 27 - 31
  • [3] Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica
    Herrero, Rolando
    Quint, Wim
    Hildesheim, Allan
    Gonzalez, Paula
    Struijk, Linda
    Katki, Hormuzd A.
    Porras, Carolina
    Schiffman, Mark
    Cecilia Rodriguez, Ana
    Solomon, Diane
    Jimenez, Silvia
    Schiller, John T.
    Lowy, Douglas R.
    van Doorn, Leen-Jan
    Wacholder, Sholom
    Kreimer, Aimee R.
    PLOS ONE, 2013, 8 (07):
  • [4] Human Papillomavirus Screening: Study of HPV prevalence and cervical cancer in North Indian Women Population
    Misra, Malvika
    Chandravati
    Tripathi, Pratima
    ANNALS OF MEDICAL AND HEALTH SCIENCES RESEARCH, 2021, 11 (06) : 1561 - 1565
  • [5] Impact of catch-up human papillomavirus vaccination on cervical cancer incidence in Kenya: A mathematical modeling evaluation of HPV vaccination strategies in the context of moderate HIV prevalence
    Liu, Gui
    Mugo, Nelly R.
    Bayer, Cara
    Rao, Darcy White
    Onono, Maricianah
    Mgodi, Nyaradzo M.
    Chirenje, Zvavahera M.
    Njoroge, Betty W.
    Tan, Nicholas
    Bukusi, Elizabeth A.
    Barnabas, Ruanne, V
    ECLINICALMEDICINE, 2022, 45
  • [6] Pre-vaccination prevalence of human papillomavirus types in the genital tract of 15-23-year-old women attending a youth health clinic in Stockholm, Sweden
    Ramqvist, Torbjorn
    Du, Juan
    Lunden, Mikaela
    Ahrlund-Richter, Sofie
    Ferreira, Joana
    Marions, Lena
    Sparen, Par
    Andersson, Soren
    Dalianis, Tina
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2011, 43 (02) : 115 - 121
  • [7] Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based study
    Ucakar, Veronika
    Poljak, Mario
    Klavs, Irena
    VACCINE, 2012, 30 (02) : 116 - 120
  • [8] Prevalence and Incidence of Anal and Cervical High-Risk Human Papillomavirus (HPV) Types Covered by Current HPV Vaccines Among HIV-Infected Women in the SUN Study
    Kojic, Erna Milunka
    Conley, Lois
    Bush, Tim
    Cu-Uvin, Susan
    Unger, Elizabeth R.
    Henry, Keith
    Hammer, John
    Escota, Gerome
    Darragh, Teresa M.
    Palefsky, Joel M.
    Brooks, John T.
    Patel, Pragna
    JOURNAL OF INFECTIOUS DISEASES, 2018, 217 (10) : 1544 - 1552
  • [9] Prevalence characteristics of cervical human papillomavirus (HPV) genotypes in the Taizhou area, China: a cross-sectional study of 37 967 women from the general population
    Xu, Hui Hui
    Lin, Aifen
    Chen, Ya Hong
    Dong, Shan Shan
    Shi, Wei Wu
    Yu, Jia Zheng
    Yan, Wei Hua
    BMJ OPEN, 2017, 7 (06):
  • [10] Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study
    Chow, Eric P. F.
    Tabrizi, Sepehr N.
    Fairley, Christopher K.
    Wigan, Rebecca
    Machalek, Dorothy A.
    Garland, Suzanne M.
    Cornall, Alyssa M.
    Atchison, Steph
    Hocking, Jane S.
    Bradshaw, Catriona S.
    Balgovind, Prisha
    Murray, Gerald L.
    Chen, Marcus Y.
    LANCET INFECTIOUS DISEASES, 2021, 21 (10) : 1448 - 1457